Meetings Between State Tobacco Monopoly Administration and Global Tobacco Companies

Jun.05.2024
Meetings Between State Tobacco Monopoly Administration and Global Tobacco Companies
State Tobacco Monopoly Administration's Deputy Director Wang Gongcheng met with high-level representatives from international tobacco companies in Beijing.

According to a report from Oriental Tobacco News, in May, Wang Gongcheng, Deputy Director of the State Tobacco Monopoly Administration, held consecutive meetings in Beijing with senior representatives from Japan Tobacco International, British American Tobacco, and Philip Morris International (PMI).


On May 7th, Wang Gongcheng, a member of the Party group and deputy director of the State Tobacco Monopoly Administration, met with the visiting President of Japan Tobacco International Asia-Pacific, Bob Yi, in Beijing. The two sides had a friendly meeting. Officials from the State Administration's Office (Foreign Affairs Department), Development Planning Department, China National Tobacco Corporation, and China Tobacco International Group Co., Ltd. also attended the meeting.


On May 16, Wang Gongcheng, a member of the party group and deputy director of the State Tobacco Monopoly Administration, met with members of the British American Tobacco Group Management Committee, including Di Giacomo Nocsk, President of the Asia-Pacific, Middle East, and Africa region, in Beijing. The two sides held friendly discussions. Participants in the meeting included officials from the State Administration Office (Foreign Affairs Department), Development Planning Department, e-cigarette management office, China Tobacco Sales Corporation, and China Tobacco International Limited.


On May 21, Wang Gongcheng, member of the Party group and deputy director of the State Tobacco Monopoly Administration, met with Philip Morris International (PMI) China's Chief Strategic Cooperation Officer Chen Jingyi and her delegation in Beijing. The two sides had a friendly discussion. Officials from the State Administration's Office (Foreign Affairs Department), Development Planning Department, Economic Operations Department, China Tobacco Sales Corporation, and China Tobacco International Limited were present at the meeting.


We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

The U.S. FDA has launched a pilot program for PMTA review of nicotine pouches to expedite the approval process and enhance regulatory efficiency
The U.S. FDA has launched a pilot program for PMTA review of nicotine pouches to expedite the approval process and enhance regulatory efficiency
In Sept 2025, the US FDA launched a nicotine pouch PMTA pilot to boost review efficiency, streamline processes and uphold strict scientific standards. Based on the "tobacco product health risk continuum" concept, it shortens cycles by focusing on key product factors and enhancing real-time communication with applicants. The FDA also urges child-resistant packaging to tackle kids’ accidental exposure, emphasizes scientific review for new tobacco products, and has approved 20 nicotine pouches so f
Sep.19 by 2FIRSTS.ai
 Indonesian National Narcotics Agency Seizes New Type of Drug E-Cigarettes: Involves Synthetic Cannabis and Ketamine
Indonesian National Narcotics Agency Seizes New Type of Drug E-Cigarettes: Involves Synthetic Cannabis and Ketamine
The Indonesian National Narcotics Agency (BNN) recently intercepted a new type of drug disguised as e-cigarettes, including synthetic cannabis smuggled from Malaysia and ketamine from France. The authorities are calling for stricter regulations to protect the public.
Aug.25 by 2FIRSTS.ai
Alan Zhao of 2Firsts: Combustibles Still Hold Strategic Value — JTI Offers New Insight into Global Tobacco Transition
Alan Zhao of 2Firsts: Combustibles Still Hold Strategic Value — JTI Offers New Insight into Global Tobacco Transition
As reduced-risk products emerge as the industry’s inevitable future, the question of how to transition has become a defining challenge for tobacco companies. In recent years, JTI has continued to invest in the combustible segment while gradually advancing its next-generation products — a path distinct from that of PMI and BAT, yet one that offers valuable insights for other legacy tobacco companies around the world.
Sep.29
WHO Criticized for Questioning FDA’s Harm Reduction Assessment, Accused of Defying Scientific Consensus
WHO Criticized for Questioning FDA’s Harm Reduction Assessment, Accused of Defying Scientific Consensus
A World Health Organization (WHO) official, Dr. Roa, recently questioned the U.S. Food and Drug Administration’s (FDA) scientific assessment of e-cigarettes and nicotine pouches, claiming there was no independent consensus and suggesting its conclusions may have been influenced by the industry. Her remarks contradict the consensus of leading international scientific bodies and are seen as a direct challenge to FDA’s credibility and to the integrity of public health science.
Aug.20 by 2FIRSTS.ai
Global Tobacco Control Policy Debate: Medical Experts Call for Science-Based Approach, Promoting Harm Reduction Over Total Bans
Global Tobacco Control Policy Debate: Medical Experts Call for Science-Based Approach, Promoting Harm Reduction Over Total Bans
Health professionals worldwide are urging a shift from abstinence-only tobacco policies toward evidence-based harm reduction. Despite bans, smoking remains prevalent in countries like India, while prohibition fuels black markets in Europe and misinformation among doctors in the U.S. Many argue that regulated alternatives could save lives where cessation fails.
Sep.09
Minnesota Teacher Charged with Sharing Marijuana Vape with Students During Utah Field Trip
Minnesota Teacher Charged with Sharing Marijuana Vape with Students During Utah Field Trip
A Minnesota teacher has been charged with three counts of drug distribution for allegedly providing a marijuana vape to underage students during a field trip in Utah.
Aug.21 by 2FIRSTS.ai